Search Result "GLP1 RA"

Export

Glucagon-Like Peptide 1 and the Cardiovascular System

Journal: Current Diabetes Reviews
Volume: 10 Issue: 5 Year: 2014 Page: 302-310
Author(s): Stephen Fava

Research Article

Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use

Journal: Current Drug Safety
Volume: 16 Issue: 1 Year: 2021 Page: 73-81
Author(s): Henrik V.B. Laursen,Johan B. Røikjer,Jakob Dal,Morten Hasselstrøm Jensen

Research Article

In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1)Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways:Implications for Suicidal Ideation and Substance Use Disorder

Journal: Current Neuropharmacology
Volume: 23 Issue: 8 Year: 2025 Page: 974-995
Author(s): Mark S. Gold,John Wesson Ashford,Panayotis K. Thanos,Gene Jack Wang,Jean Lud Cadet,Eliot L. Gardner,Jag H. Khalsa,Eric R. Braverman,Catherine A. Dennen,Edward J. Modestino,Paul R. Carney,Rossano Kepler Alvim Fiorelli,Aryeh R. Pollack,Rajendra D. Badgaiyan

Perspective

Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials

Journal: Current Diabetes Reviews
Volume: 16 Issue: 9 Year: 2020 Page: 917-921
Author(s): Samit Ghosal,Binayak Sinha

Review Article

Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 17 Year: 2018 Page: 1879-1886
Author(s): Michael Doumas,Κonstantinos Imprialos,Konstantinos Stavropoulos,Andromachi Reklou,Alexandros Sachinidis,Vasilios G. Athyros

Review Article

The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?

Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 254-268
Author(s): Marianna Papademetriou,Vasilios G. Athyros,Eleni Geladari,Michael Doumas,Costas Tsioufis,Vasilios Papademetriou

Review Article

Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review

Journal: Current Diabetes Reviews
Volume: 16 Issue: 8 Year: 2020 Page: 820-832
Author(s): Asim Ahmed Elnour,Noora Al Hajri,Israa Yousif El Khidir,Abdulla AlAmoodi,Sahar Asim Ahmed,Adel Sadeq

Perspectives in vascular pharmacology

What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?

Journal: Current Vascular Pharmacology
Volume: 17 Issue: 5 Year: 2019 Page: 425-428
Author(s): Michael Doumas,Konstantinos Imprialos,Konstantinos Stavropoulos,Vasilios G. Athyros

Review Article

GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta

Diabetes Therapy: Novel Patents Targeting the Glucose-Induced Insulin Secretion

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 4 Issue: 1 Year: 2010 Page: 1-9
Author(s): Sergio Polakof

Previous   Next

Go to   Results 1 - 1 of 117

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type